Amarantus Bioscience Holdings Inc (AMBS)

[redspeed]

I wouldn't worry about them. Some very immature posts as usual. They were all pumping this morning and sold out this afternoon. Goodbye for now. Gives me more time to continue to accumulate.

More importantly, the recording is up and running.

Here's a few notes as I'm starting to listen to it again.


- 3 orphans and two more on the way. A year ago none.
- Opportunity for PRV which are selling at a average of $300M
- ESS operating under non-diluted funding from AFRIM.
- Potential for continued support. $130M awarded just yesterday. ESS was presented to a special panel in May. The data will be presented in Q4
- First gen ESS likely and immediate benefit for patients, but other things can be added to make it truly revolutionary and expand into a number of other areas